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PURPOSE. We compared the area of the foveal avascular zone (FAZ) and macular capillary
network density at different retinal layers using swept-source optical coherence tomography
angiography (OCT-A) in normal individuals and patients with diabetic retinopathy (DR).
METHODS. Images (a 3 3 3 mm cube centered on the fovea) were acquired in 40 eyes of 22
normal individuals and 28 eyes of 18 patients with varying levels of DR using a swept-source
OCT-A device (central wavelength 1050 nm; A-scan-rate of 100,000 scans per second). En face
images of the retinal vasculature were generated from the superficial and deep retinal layers
(SRL/DRL). Quantitative analysis of the vessel density (VD) and FAZ area was performed.
Vessel density was assessed as the ratio of the retinal area occupied by vessels.
RESULTS. Among the DR subjects (mean age, 72 years; 61% male), 35.7% of the eyes had mild,
35.7% moderate, and 7.1% severe nonproliferative DR (NPDR), and 21.4% and proliferative
DR (PDR). The mean FAZ area in patients with DR and in normal individuals was 0.518 and
0.339 mm2, respectively, for the SRL (P ¼ 0.003), and 0.615 and 0.358 mm2, respectively, for
the DRL (P < 0.001). The mean VD (ratio) at the SRL and DRL was statistically significantly
lower in patients with DR (SRL, P < 0.001; DRL, P ¼ 0.028).
CONCLUSIONS. Swept-source OCT-A of the microcirculation in eyes of patients with DR can be
used to quantitatively demonstrate alterations in the FAZ and VD in the SRL/DRL of the
macula compared to normal eyes. Future longitudinal studies may use these metrics to
evaluate changes over time or in response to treatment.
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Diabetic retinopathy (DR) is the leading cause of visualimpairment and blindness in most developed countries.1,2
Since the number of patients with DR is expected to grow, and
early detection and intervention is useful in terms of preventing
severe vision loss,3–6 further investigations are needed regard-
ing new methods for evaluating the microvascular status and
therapeutic effect of treatment.
The macular microvasculature is a complex system consist-
ing of three capillary plexuses, which are responsible for the
blood supply of the inner retina: the superficial retinal layer
(SRL) located in the retinal nerve fiber layer, and the two
plexuses located at the inner and outer border of the inner
nuclear layer, which together make up the deep retinal layer
(DRL).7 The outer retina and foveal avascular zone depend on
diffusion from the choroidal circulation.8 It has been reported
that retinal blood flow decreases in patients with type 2
diabetes mellitus who have no or mild DR, suggesting that the
retinal microvasculature becomes impaired in early-stage DR,
even in patients with no evidence of retinopathy.9 Previous
histologic studies have shown capillary nonperfusion to be an
important feature of this vascular disease.10 In vivo, the gold
standard to screen for DR is dilated biomicroscopic fundus
examination. Fluorescein angiography (FA) is more sensitive
than examination to detect early microvascular changes.11
Previous studies have shown enlargement of the intercapillary
areas in patients with DR and decreased capillary perfusion
density.12 Since FA takes several minutes and requires the
administration of an intravenous dye, the technique is not
optimal for screening or frequent longitudinal assessments.11,13
In addition, leakage of fluorescein dye and the superimposition
of capillaries from different retinal layers onto a single two-
dimensional FA image have hindered a more detailed investi-
gation of the microvasculature by FA.
This is particularly important, since recent evidence
suggests that a diabetic retinal neuropathy and loss of
photoreceptors may precede the development of an overt
retinal vasculopathy.14 The deep retinal capillary circulation,
however, supplies nourishment to the photoreceptor zones
(Henle’s layer), especially during systemic hypoxia as the
choroidal vasculature fails to autoregulate the blood supply.15
One wonders whether subtle, selective alterations to the deep
capillary plexus, not visible by FA, could have a role in the
pathophysiology of early diabetic retinal neuropathy.
Optical coherence tomography angiography (OCT-A) is a
novel, noninvasive method of visualizing the retinal microcir-
culation in a depth-resolved fashion, allowing the superficial
iovs.arvojournals.org j ISSN: 1552-5783 3907
This work is licensed under a Creative Commons Attribution 4.0 International License.
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/Journals/IOVS/935424/ on 07/30/2016
and deep capillary plexuses to be studied separately.16,17 In
addition, because contrast between retinal vessels and
surrounding tissues is high, OCT-A lends itself to segmentation
and quantification of the retinal microvasculature. We and
others have shown that the superficial and deep capillary
circulation can be quantified reliably, with important quanti-
tative and qualitative differences apparent between the deep
and superficial layers.18–20 Ishibazawa et al.21 described, in a
pilot study, the pathologic vascular changes of DR, including
microaneurysms, retinal nonperfusion, and neovascularization.
de Carlo et al.22 found enlargement and remodeling of the
foveal avascular zone (FAZ) area in eyes of subjects with
diabetes but without clinical DR. Quantitative comparisons
between normal eyes and eyes with DR, however, still are
limited, particularly for swept-source based OCT-A devices.
Swept-source OCT technology uses longer-wavelength infrared
light with less sensitivity roll-off with depth compared to
conventional spectral-domain OCT. This allows a deeper
penetration into tissue and better imaging through optical
opacities. While this sensitivity benefit may be most apparent
for choroidal vascular imaging, it also may be relevant to
situations with marked retinal thickening, such as with severe
macular edema. In addition, different OCT-A instruments use
different proprietary flow detection and segmentation algo-
rithms, which may yield different results. Thus, the microvas-
cular abnormalities must be studied with various devices to
better define the potential discrepancies.
The aim of this study was to evaluate the FAZ area and
perifoveal capillary network density in the SRL and DRL in
patients with varying severities of DR, and to compare the
findings to those of normal individuals using a swept-source
OCT-A.
METHODS
Study Population
This study was approved by the Institutional Review Board of
the University of California Los Angeles (UCLA) and conducted
in accordance with the ethical standards stated in the
Declaration of Helsinki. Informed consent was obtained from
all examined patients and healthy individuals to participate in
this research. The study included 28 eyes of 18 diabetic
patients with DR and 40 eyes of 22 healthy individuals.
FIGURE 1. Swept-source OCT-A images of three subjects centered on the fovea. (A, B) En face projection image of the foveal avascular zone
(outlined) of the superficial and DRLs in a healthy individual with segmentation. (C, D) Corresponding en face projection images of a patient with
DR without DME. (E, F) En face OCT-A images of a patient with DR with DME.
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Patients were recruited prospectively at Doheny Eye
Institute, UCLA, between September and December 2015.
There was no age criterion for enrollment in the study, but all
subjects had a known diagnosis of diabetes mellitus, previously
confirmed by laboratory testing by their primary care
physician.
The subjects of the control group were deemed to be
normal based on the absence of any previous ocular history,
any systemic diseases, or any visual symptoms; a normal-
appearing retina on clinical examination; and a normal
reflectance OCT of the macula.
Swept-Source OCT-A
The images were obtained using a swept-source OCT device
(DRI OCT Triton; Topcon Corporation, Tokyo, Japan) with a
central wavelength of 1050 nm, an acquisition speed of
100,000 A-scans per second, and an axial and transversal
resolution of 7 and 20 lm in tissue, respectively. Scans were
taken from 33 3 mm cubes with each cube consisting of 320
clusters of four repeated B-scans centered on the fovea. En face
images of the retinal vasculature were generated from the SRL
and DRL, based on the automated layer segmentation
performed by the OCT instrument software. The en face
images of the superficial capillary network were derived from
an en face slab, extending from the internal limiting membrane
to the inner border of the inner nuclear layer. The en face
images of the DRL were derived from a slab that extended from
the inner border of the inner nuclear layer to the outer border
of the inner nuclear layer.
Quantitative Measurements and Statistical Analysis
Quantitative analysis was performed using the publically
available GNU Image Manipulation Program GIMP 2.8.14
(available in the public domain at http://gimp.org).
The FAZ area was defined as the area inside the central
border of the capillary network, which was outlined manually
for the SRL and DRL in accordance with our previously
described technique (Fig. 1).18 The graders used the ‘‘scissors’’
tool of the GIMP software to outline the border of the FAZ area.
The software calculated the outlined area in pixels. The area
then was calculated based on the 320-pixel width of the
images. The measured area in pixels was converted to
FIGURE 2. Swept-source OCT-A images of three subjects centered on the fovea. (A, B) En face projection image of the vessel density of the
superficial and DRLs in a healthy individual. (C, D) Corresponding en face projection images of a patient with DR without DME. (E, F) En face OCT-A
images of a patient with DR with DME.
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millimeters based on the scan dimensions (3 3 3-mm scan).
The visible vessels in the SRL and DRL in the entire 3 3 3
macula scan were extracted using the color selection tool (Fig.
2). Vessel density (VD) was assessed as the ratio of area
occupied by vessels.
The FAZ area and VD were measured by two independent,
masked Doheny Image Reading Center graders. The measure-
ments made by the main grader were used for the analysis,
while those made by the second grader were used only to
calculate the intergrader agreement.
The Kolmogorov-Smirnov test was used for normality.
Student’s t-test for unpaired samples was used to compare
each layer of the two groups. We used SPSS statistical software
version 21 (SPSS, Inc., IBM Company, Chicago, IL, USA) for
statistical analysis. A P value of <0.05 was considered
significant. Intraclass correlation coefficients (ICC) with 95%
confidence intervals (CIs) were calculated to assess intergrader
agreement.
RESULTS
A total of 28 eyes of 18 patients with DR were included in this
study. The mean age of the patients with DR was 72 years
(range, 54–93), and 11 (61%) were male and 7 (39%) were
female. There were 15 (83%) white and 3 (17%) Hispanic
patients. Of the eyes, 10 (35.7%) had mild, 10 (35.7%)
moderate, and 2 (7.1%) severe nonproliferative DR (NPDR),
and 6 (21.4%) had proliferative DR (PDR). A total of 13 eyes
(46.2%) had evidence of diabetic macula edema (DME) on
clinical exam and/or OCT at the time of image acquisition.
Among the eyes with DME, 5 had mild and 6 moderate NPDR,
and 2 had PDR. Among the patients without DME, 5 had mild,
4 had moderate, and 2 had severe NPDR, and 4 had PDR.
We evaluated 40 eyes of 22 healthy individuals in this study.
The average age of control subjects was 39 years (range, 30–
58); 9 were men and 14 were women; 16 were white, 1 black,
and 4 Hispanic.
The mean (SD) FAZ area in the SRL was 0.518 (0.273) mm2
in the DR group, and 0.339 (0.118) mm2 in the control group
(P¼ 0.003; Fig. 3, Table 1). The mean (SD) FAZ area in the DRL
was 0.615 (0.237) mm2 in the DR group and 0.358 (0.105)
mm2 in healthy individuals (P < 0.001; Fig. 3, Table 1). After
dividing the groups based on their DR stage, the mean VD (SD)
and mean FAZ area (SD) are shown in Table 2. Comparing
those subgroups to healthy individuals, there was a statistically
significant difference in the FAZ area in the SRL in patients with
severe NPDR and PDR (P ¼ 0.301 in mild, P ¼ 0.199 in
moderate, and P < 0.001 in severe NPDR, and P < 0.001 in the
PDR group). In the DRL, all subgroups showed a statistically
significant difference in the FAZ area (P < 0.001 in mild, P ¼
0.029 in moderate, and P ¼ 0.001 in severe NPDR, and P ¼
0.027 in the PDR group). The mean difference between the
two graders was 0.012 6 0.030 mm2 for the SRL and 0.011 6
0.041 mm2 for the DRL. The ICC was 0.997 (95% CI, 0.993–
0.999) and 0.992 (95% CI, 0.983–0.996) for the SRL and DRL.
The mean VD was statistically significantly lower in patients
with DR in the SRL and DRL. In the SRL, the mean (SD) VD
ratio was 0.567 (0.097) in patients with DR and 0.709 (0.038)
in normal individuals (P < 0.001; Fig. 4, Table 3). In the DRL,
the mean (SD) ratio was 0.668 (0.099) and 0.714 (0.049),
respectively, (P ¼ 0.028; Fig. 4, Table 3). After dividing the
FIGURE 3. Boxplot showing the FAZ area in the SRLs and DRLs in healthy individuals, patients with DR and subgroups of patients with DR.
TABLE 1. Mean (SD) Area of the FAZ Area in mm2 in the SRL and DRL
FAZ Area, mm2
P ValueDR, Mean 6 SD
Normal Individuals,
Mean 6 SD
SRL 0.518 6 0.273 0.339 6 0.118 0.003
DRL 0.615 6 0.237 0.358 6 0.105 <0.001
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groups based on their DR stage, the mean VD (SD) and mean
FAZ area (SD) are shown in Table 2. Comparing those
subgroups to healthy individuals, there was a statistically
significant difference in the VD in the SRL in patients with mild
or moderate NPDR as well as PDR (P value 0.004 in mild, 0.003
in moderate, and 0.148 in severe NPDR, and 0.002 in the PDR
group). There was no statistically significant difference in the
DRL compared to healthy individuals. The mean difference
between the two graders was 0.010 6 0.032 for the SRL and
0.015 6 0.059 for the DRL. The ICC was 0.972 (95% CI, 0.941–
0.987) and 0.889 (95% CI, 0.764–0.948) for the SRL and DRL.
Dividing the cohort with regard to the presence of DME
(46.42%, 13 eyes) at time of exam, we found a statistically
significant difference in the VD in the DRL compared to
healthy individuals. The mean (SD) VD in the group of patients
with DME was 0.534 (0.088) and 0.617 (0.070) in the SRL and
DRL, respectively. In the patients without DME, the VD was
0.594 (0.099) and 0.706 (0.102) in the SRL and DRL,
respectively (Table 4). The mean VD in patients with DME
was statistically significantly lower than patients without DME.
DISCUSSION
This study evaluated the FAZ area and VD of the macular
capillary network, using swept-source OCT-A in patients with
DR. We observed a statistically significant enlargement of the
FAZ and a lower VD of the capillary network in the SRL and
DRL compared to healthy individuals.
Previous studies have used FA to identify enlargement of the
FAZ area in patients with DR. In these studies, there was a
strong correlation between the FAZ area and severity of the
capillary nonperfusion.12,23 Others defined the enlargement of
the FAZ area as an indicator of DR progression.24 Using OCT-A,
our study showed a statistically significant enlargement in
patients with DR at the SRL and DRL, suggesting that
progressive nonperfusion in these patients was not limited to
a particular layer. These results are consistent with other
previous reports.25–27 Furthermore, we measured the VD in
each layer of the retina. As seen in Table 3, there was a
statistically significant decrease in VD in the SRL and DRL
between patients with DR and healthy individuals. Although
both layers were affected, a more consistent and severe
decrease in VD was observed in the SRL. This observation is
FIGURE 4. Boxplot showing the VD ratio as the retinal area occupied by vessels in the SRLs and DRLs in healthy individuals, those with DR and
subgroups of patients with DR.
TABLE 2. Mean (SD) of the VD (Ratio) and FAZ Area in the SRL and DRL in the Different Stages of DR
Mild NPDR Moderate NPDR Severe NPDR PDR
Mean 6 SD P Value Mean 6 SD P Value Mean 6 SD P Value Mean 6 SD P Value
FAZ in mm2
SRL 0.498 6 0.401 0.301 0.444 6 0.191 0.199 0.681 6 0.006 <0.001 0.619 6 0.119 <0.001
DRL 0.608 6 0.187 <0.001 0.546 6 0.250 0.029 0.643 6 0.086 0.001 0.734 6 0.314 0.027
VD, ratio
SRL 0.591 6 0.097 0.004 0.566 6 0.114 0.003 0.589 6 0.043 0.148 0.519 6 0.081 0.002
DRL 0.699 6 0.076 0.544 0.649 6 0.118 0.122 0.704 6 0.079 0.773 0.636 6 0.017 0.136
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consistent with a recent study demonstrating that the macular
superficial capillary network in diabetics has more extensive
nonperfused areas than the DRL.21 Considering the subgroups
of patients with DR, the VD in the SRL in patients with mild or
moderate NPDR and PDR was statistically significantly lower
compared to normal individuals, whereas the VD in the DRL
did not show a statistically significant difference. Upon further
subdivision of the DR group based on the presence of DME, we
observed a reduced VD in the DRL in eyes with DME compared
to those without DME. We speculate that this difference may
be related to the presence of cystoid changes, which appear as
areas of no-flow and are included in the nonperfusion
computation. Such an effect has been demonstrated by de
Carlo et al.28 However, if the vessels are simply displaced by
the cysts and not actually lost, creating a thicker en face slab
that includes the entire cyst and surrounding tissue may allow
this question to be explored further.
The variability in capillary density measurements was
greater among the eyes with DR compared to the normal
eyes. This likely reflects, in part, the varying severities of
retinopathy within the diabetic cohort. Patients with mild-to-
moderate NPDR seemed to have a smaller FAZ and a higher
capillary density compared to patients with more severe
retinopathy; however, our study was not powered to make
these comparisons.
Despite the relatively small cohort size, the high repeatabil-
ity of our measurements gives us confidence that the
differences between the diabetic and normal eyes are reliable.
The repeatability between graders for FAZ area and capillary
density was excellent with an ICC of 0.997 and 0.992 for the
FAZ and 0.972 and 0.889 for the VD, and a coefficient of
variation of 0.01.
In contrast to previous studies, we used a swept-source
OCT-A with a light source centered at 1050 nm, which can
penetrate tissues to a greater extent with less sensitivity roll-off
with depth. This potentially could be an advantage for
evaluating the microcirculation in the setting of markedly
thickened or edematous retinas.
In addition to the small number of subjects with specific
severities of retinopathy, our study has other limitations,
which should be considered when assessing our findings.
First, our measurements were based on a single session. It is
not known whether the result would have differed if we
repeated the OCT-A scans a few days later. We have, however,
previously studied the repeatability of OCT-A measurements
between sessions, and we have found them to have a high
degree of reproducibility. Another limitation of this study is
that the number of normal subjects was small, and their mean
age was younger than that of the patients with DR. An
additional limitation of the present study is the small field of
view (333 mm). A larger field of view using OCT-A may allow
further investigation, such as the correlation between FAZ
area and extent of ischemia in the periphery. Although scans
with a larger field of view may be obtained, it is at the
expense of lateral resolution, which may impair accurate
capillary measurements. Future advances allowing montaging
of multiple scan acquisitions may partially address this
limitation. Another major limitation of current OCT-A
technology is the accuracy of segmentation algorithms,
particularly in diseases featuring significant disruption of the
retinal layers. Instrument software does allow correction of
these segmentation errors, but such correction would be
impractical when hundreds of individual B-scans would need
to be corrected per case. Further improvement of the
automated segmentation or the development of more
efficient semiautomated correction tools is required. Another
limitation of existing OCT-A devices is the background noise,
which could affect the quantitative measurements as it could
be mistaken as flow and mistakenly included in the VD
measurement.
In summary, in this study we were able to use swept-source
OCT-A to reliably demonstrate an enlargement of the FAZ area
and a reduction in retinal capillary density in the SRL and DRL
in eyes with DR. Our findings highlight the potential role of
OCT-A in monitoring and quantifying retinal vascular alter-
ations in diabetes.29
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